Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-23

Clinical Trial Update: Evaluating Efficacy of the Dexmedetomidine Transdermal System for Postoperative Analgesia Following Abdominoplasty [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the dexmedetomidine transdermal system for postoperative analgesia after abdominoplasty.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine Transdermal System (dexmedetomidine)

Snippet

Sponsor: Teikoku Pharma USA, Inc. | Conditions: Pain, Postoperative | Phase 2 | Status: UNKNOWN